Nelfinavir: Difference between revisions
Jump to navigation
Jump to search
| Line 30: | Line 30: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Nelfinavir is an inhibitor of the HIV-1 protease. Inhibition of the viral protease prevents cleavage of the gag and gag-pol polyprotein resulting in the production of immature, non-infectious virus.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VIRACEPT (NELFINAVIR MESYLATE) TABLET, FILM COATED VIRACEPT (NELFINAVIR MESYLATE) POWDER [AGOURON PHARMACEUTICALS INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd#nlm34089-3 | publisher = | date = | accessdate}}</ref> | |||
==References== | ==References== | ||
Revision as of 16:44, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
VIRACEPT®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Nelfinavir is an inhibitor of the HIV-1 protease. Inhibition of the viral protease prevents cleavage of the gag and gag-pol polyprotein resulting in the production of immature, non-infectious virus.[1]
References
- ↑ "VIRACEPT (NELFINAVIR MESYLATE) TABLET, FILM COATED VIRACEPT (NELFINAVIR MESYLATE) POWDER [AGOURON PHARMACEUTICALS INC]". Text " accessdate" ignored (help)